Litcius/Paper detail

Efficient photorelease of carbon monoxide from a luminescent tricarbonyl rhenium(<scp>i</scp>) complex incorporating pyridyl-1,2,4-triazole and phosphine ligands

Ángel D. Hernández Mejías, Alexandre Poirot, Meriem Rmili, Nadine Leygue, Mariusz Wolff, Nathalie Saffon‐Merceron, Éric Benoist, Suzanne Fery‐Forgues

2021Dalton Transactions20 citationsDOIOpen Access PDF

Abstract

Precise control over the production of carbon monoxide (CO) is essential to exploit the therapeutic potential of this molecule. The development of photoactive CO-releasing molecules (PhotoCORMs) is therefore a promising route for future clinical applications. Herein, a tricarbonyl-rhenium(i) complex (1-TPP), which incorporates a phosphine moiety as ancilliary ligand for boosting the photochemical reactivity, and a pyridyltriazole bidentate ligand with appended 2-phenylbenzoxazole moiety for the purpose of photoluminescence, was synthesized and characterized from a chemical and crystallographic point of view. Upon irradiation in the near-UV range, complex 1-TPP underwent fast photoreaction, which was monitored through changes of the UV-vis absorption and phosphorescence spectra. The photoproducts (i.e. the dicarbonyl solvento complex 2 and one CO molecule) were identified using FTIR, 1H NMR and HRMS. The results were interpreted on the basis of DFT/TD-DFT calculations. The effective photochemical release of CO associated with clear optical variations (the emitted light passed from green to orange-red) could make 1-TPP the prototype of new photochemically-active agents, potentially useful for integration in photoCORM materials.

Topics & Concepts

MoietyChemistryPhotochemistryRheniumCarbon monoxidePhosphineLigand (biochemistry)DenticityMoleculePhosphorescenceReactivity (psychology)Combinatorial chemistryStereochemistryCatalysisOrganic chemistryCrystal structureFluorescencePhysicsBiochemistryQuantum mechanicsMedicinePathologyReceptorAlternative medicineHeme Oxygenase-1 and Carbon MonoxidePharmacological Receptor Mechanisms and EffectsMethemoglobinemia and Tumor Lysis Syndrome